FimmCyte
Basel
About FimmCyte
FimmCyte develops a novel disease modifying treatments for fibro-inflammatory diseases, starting with Endometriosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Funding stage: Seed
- Last round: Convertible Note (Feb 2024)
- Website: fimmcyte.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/fimmcyte-95854 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.